Market News - Page 693

The Company today announces that certain PDMRs and an employee have exercised options over 4,824,421 ordinary shares of 0.1 pence each in the capital of the Company (“Ordinary Shares”). Martin Harrison, CEO, exercised 3,000,000 options under the Company's 2015 Enterprise Management Incentive Scheme (“EMI”), at an exercise price of 7.75 pence per share. Furthermore, he also exercised 957,000 options under the Company's 2016 Growth Share Scheme (“GSS”), in accordance with the terms of the scheme. These options have vested in full with the Company having achieved the relevant performance criteria in 2014 and 2016. Mr Harrison subsequently sold 3,000,000 Ordinary Shares at 70 pence per share….

B.P. Marsh & Partners Plc (AIM: BPM), the niche venture capital provider to early stage financial services businesses, announces that CBC UK Limited (“CBC”) has completed the 100% acquisition of PBS Insurance Limited (“PBS”)….

Nestlé's Board of Directors and management team are implementing an accelerated long-term value creation strategy for one of the world's leading global consumer goods companies. Through swift and decisive action, the company's Board and management are delivering results. …

McBride plc, the leading European manufacturer and supplier of Co-manufactured and Private Label products for the Household and Personal Care market, provides the following trading update for the twelve months ending 30 June 2018….

Entertainment One Ltd. is pleased to announce that further to its initial investment in 2015, the Group has completed the purchase of the remaining stake in leading feature film production and global sales company Sierra Pictures LLC, which results in full ongoing ownership by the Group….

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US today announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has approved Lynparza (olaparib) tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 negative breast cancer who have received prior chemotherapy. Patients are selected for therapy based on an approved companion diagnostic….

The Alliance will cover the strategic relationship with global suppliers, the joint purchasing of own brand products and goods not for resale. It will be governed by a three-year operational framework….

Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, is pleased to announce the appointment of Alex Raeber as Chief Scientific Officer. Alex will join the Board as an Executive Director and is expected to commence his new role in early October. …